专利检索 ap:("SillaJen, Inc.") AND inv:"Chan KIM" 第 1 页

1.

发明申请
ONCOLYTIC VACCINIA VIRUS AND CHECKPOINT INHIBITOR COMBINATION THERAPY 审中-公开

公开(公告)号：US20200085891A1

公开(公告)日：2020-03-19

申请号：US16606681

申请日：2018-04-23

申请人： SillaJen, Inc.

发明人： Chan KIM , Hongjae JEON , Eun Sang MOON , Sungkuon CHI , Jiwon Sarah CHOI , Joon-goo JUNG , Jungu BAE

IPC分类号： A61K35/768 , C12N7/00 , A61K38/19 , A61K9/00 , A61K39/395 , A61P35/00 , A61K45/06

摘要： A pharmaceutical combination comprising (i) a replicative oncolytic vaccinia virus and (ii) an immune checkpoint protein inhibitor is provided as well as a kit comprising the pharmaceutical combination and methods for treating and/or preventing cancer.

2.

发明公开
CANCER TREATMENTS 审中-公开

公开(公告)号：US20240252563A1

公开(公告)日：2024-08-01

申请号：US18163015

申请日：2023-02-01

申请人： SillaJen, Inc.

发明人： Chan KIM , Hongjae JEON , Eun Sang MOON , Sungkuon CHI , Jiwon Sarah CHOI , Joon-goo JUNG , Jungu BAE

IPC分类号： A61K35/768 , A61K38/19 , A61K39/395 , A61P35/00

CPC分类号： A61K35/768 , A61K38/193 , A61K39/3955 , A61P35/00

摘要： A pharmaceutical combination comprising (i) a replicative oncolytic vaccinia virus and (ii) an immune checkpoint protein inhibitor is provided as well as a kit comprising the pharmaceutical combination and methods for treating and/or preventing cancer.